Correlation Between Integra LifeSciences and DexCom

Can any of the company-specific risk be diversified away by investing in both Integra LifeSciences and DexCom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Integra LifeSciences and DexCom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Integra LifeSciences Holdings and DexCom Inc, you can compare the effects of market volatilities on Integra LifeSciences and DexCom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Integra LifeSciences with a short position of DexCom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Integra LifeSciences and DexCom.

Diversification Opportunities for Integra LifeSciences and DexCom

0.65

Correlation Coefficient

Integra LifeSciences  DexCom

Poor diversification

The 3 months correlation between Integra and DexCom is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Integra LifeSciences Holdings and DexCom Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DexCom Inc and Integra LifeSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Integra LifeSciences Holdings are associated (or correlated) with DexCom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DexCom Inc has no effect on the direction of Integra LifeSciences i.e., Integra LifeSciences and DexCom go up and down completely randomly.

Pair Corralation between Integra LifeSciences and DexCom

Given the investment horizon of 90 days Integra LifeSciences Holdings is expected to under-perform the DexCom. But the stock apears to be less risky and, when comparing its historical volatility, Integra LifeSciences Holdings is 1.33 times less risky than DexCom. The stock trades about -0.13 of its potential returns per unit of risk. The DexCom Inc is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  7,446  in DexCom Inc on September 22, 2024 and sell it today you would earn a total of  558.00  from holding DexCom Inc or generate 7.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Integra LifeSciences Holdings  vs.  DexCom Inc

Integra LifeSciences

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Integra LifeSciences Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Integra LifeSciences unveiled solid returns over the last few months and may actually be approaching a breakup point.

DexCom Inc

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, DexCom displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Integra LifeSciences and DexCom

The main advantage of trading using opposite Integra LifeSciences and DexCom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Integra LifeSciences position performs unexpectedly, DexCom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DexCom will offset losses from the drop in DexCom's long position.

The idea behind Integra LifeSciences Holdings and DexCom Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.